Cover image for Automated image detection of retinal pathology
Title:
Automated image detection of retinal pathology
Publication Information:
Boca Raton : CRC Press, c2010
Physical Description:
xviii, 359 p., [16] p. of plates : ill. (some col.) ; 24 cm.
ISBN:
9780849375569

Available:*

Library
Item Barcode
Call Number
Material Type
Item Category 1
Status
Searching...
30000010245222 RE551 A97 2010 Open Access Book Book
Searching...

On Order

Summary

Summary

Discusses the Effect of Automated Assessment Programs on Health Care Provision

Diabetes is approaching pandemic numbers, and as an associated complication, diabetic retinopathy is also on the rise. Much about the computer-based diagnosis of this intricate illness has been discovered and proven effective in research labs. But, unfortunately, many of these advances have subsequently failed during transition from the lab to the clinic. So what is the best way to diagnose and treat retinopathy? Automated Image Detection of Retinal Pathology discusses the epidemiology of the disease, proper screening protocols, algorithm development, image processing, and feature analysis applied to the retina.

Conveys the Need for Widely Implemented Risk-Reduction Programs

Offering an array of informative examples, this book analyzes the use of automated computer techniques, such as pattern recognition, in analyzing retinal images and detecting diabetic retinopathy and its progression as well as other retinal-based diseases. It also addresses the benefits and challenges of automated health care in the field of ophthalmology. The book then details the increasing practice of telemedicine screening and other advanced applications including arteriolar-venous ratio, which has been shown to be an early indicator of cardiovascular, diabetes, and cerebrovascular risk.

Although tremendous advances have been made in this complex field, there are still many questions that remain unanswered. This book is a valuable resource for researchers looking to take retinal pathology to that next level of discovery as well as for clinicians and primary health care professionals that aim to utilize automated diagnostics as part of their health care program.


Author Notes

Herbert Jelinek, Charles Stuart University, Albury, New South Wales, Australia

Michael J. Cree, University of Waikato, Hamilton, New Zealand


Table of Contents

H. F. Jelinek and M. J. CreeD. Worsley and D. SimmonsM. D. Abrámoff and M. NiemeijerL B. BäcklundA. OsarehM. J. CreeN. Cheung and T. Y. Wong and L. HodgsonJ. V. B. Soares and R. M. Cesar Jr.K. H. Fritzsche and C. V. Stewart and B. RoysamN. W. Witt and M. E. Martínez-Pérez and K. H. Parker and S. A. McG. Thorn and A. D. HughesK. Yogesan and F. Reinholz and L J. Constable
Prefacep. xiii
Contributorsp. xvii
1 Introductionp. 1
1.1 Why Automated Image Detection of Retinal Pathology?p. 1
1.1.1 The general clinical needp. 2
1.1.2 Diabetes: A global problemp. 2
1.1.3 Diabetic retinopathyp. 2
1.1.4 Eye-screening for diabetic retinopathyp. 3
1.1.5 Other retinal pathologiesp. 5
1.1.6 The retina as an indicator for disease elsewherep. 6
1.1.7 Research needs in automated retinopathy detectionp. 6
1.1.8 The engineering opportunityp. 7
1.2 Automated Assessment of Retinal Eye Diseasep. 7
1.2.1 Automated microaneurysm detection in diabetic retinopathyp. 8
1.2.2 Hemorrhagesp. 9
1.2.3 White lesion segmentationp. 9
1.2.4 Localization of important markersp. 10
1.2.5 Retinal vessel diameter changes in diseasep. 11
1.2.6 Retinal blood vessel segmentationp. 11
1.2.7 Mathematical analysis of vessel patternsp. 12
1.3 The Contribution of This Bookp. 13
2 Diabetic Retinopathy and Public Healthp. 27
2.1 Introductionp. 27
2.2 The Pandemic of Diabetes and Its Complicationsp. 28
2.3 Retinal Structure and Functionp. 29
2.4 Definition and Descriptionp. 35
2.5 Classification of Diabetic Retinopathyp. 40
2.6 Differential Diagnosis of Diabetic Retinopathyp. 40
2.7 Systemic Associations of Diabetic Retinopathyp. 42
2.7.1 Duration of diabetesp. 42
2.7.2 Type of diabetesp. 42
2.7.3 Blood glucose controlp. 42
2.7.4 Blood pressurep. 42
2.7.5 Serum lipidsp. 43
2.7.6 Renal diseasep. 43
2.7.7 Anemiap. 43
2.7.8 Pregnancyp. 43
2.7.9 Smokingp. 43
2.8 Pathogenesisp. 43
2.8.1 Hyperglycemiap. 43
2.8.2 Hematological abnormalitiesp. 44
2.8.3 Leukostasis and inflammationp. 44
2.8.4 Growth factorsp. 44
2.8.5 Neurodegenerationp. 45
2.9 Treatmentp. 45
2.9.1 Management of systemic associationsp. 45
2.9.2 Ocular treatmentsp. 45
2.9.3 Investigational treatmentsp. 46
2.10 Screeningp. 48
2.10.1 Methods of screeningp. 48
2.10.2 Frequency of screeningp. 54
2.10.3 Cost effectiveness of screeningp. 54
2.10.4 Access to care and screeningp. 54
2.11 Conclusionp. 55
3 Detecting Retinal Pathology Automatically with Special Emphasis on Diabetic Retinopathyp. 67
3.1 Historical Asidep. 67
3.2 Approaches to Computer (Aided) Diagnosisp. 68
3.3 Detection of Diabetic Retinopathy Lesionsp. 70
3.4 Detection of Lesions and Segmentation of Retinal Anatomyp. 71
3.5 Detection and Staging of Diabetic Retinopathy: Pixel to Patientp. 71
3.6 Directions for Researchp. 72
4 Finding a Role for Computer-Aided Early Diagnosis of Diabetic Retinopathyp. 79
4.1 Mass Examinations of Eyes in Diabetesp. 79
4.1.1 Motive for accurate early diagnosis of retinopathyp. 80
4.1.2 Definition of screeningp. 81
4.1.3 Practical importance of the concept of screeningp. 81
4.1.4 Coverage and timely re-examinationp. 81
4.2 Developing and Defending a Risk Reduction Programp. 82
4.2.1 Explaining why retinopathy is suitable for screeningp. 82
4.2.2 Understanding reasons for possible criticismp. 83
4.2.3 Fulfilling criteria for screening testsp. 83
4.2.4 Setting quality assurance standardsp. 84
4.2.5 Training and assessmentp. 84
4.3 Assessing Accuracy of a Diagnostic Testp. 84
4.3.1 Predictive value, estimation, powerp. 85
4.3.2 Receiver operating characteristic curvep. 87
4.3.3 Area under curvep. 89
4.3.4 Covariatesp. 90
4.4 Improving Detection of Diabetic Retinopathyp. 90
4.4.1 Improving work environmentp. 91
4.4.2 Going digitalp. 91
4.4.3 Obtaining clear imagesp. 91
4.4.4 Avoiding loss of informationp. 92
4.4.5 Viewing imagesp. 92
4.4.6 Ensuring accurate gradingp. 93
4.4.7 Organizing for successp. 93
4.5 Measuring Outcomes of Risk Reduction Programsp. 93
4.5.1 Reducing new blindness and visual impairmentp. 94
4.5.2 Counting people who lost visionp. 94
4.5.3 Understanding the importance of visual impairmentp. 95
4.6 User Experiences of Computer-Aided Diagnosisp. 96
4.6.1 Perceived accuracy of lesion detectionp. 97
4.6.2 Finding and reading evaluations of software for retinopathy diagnosisp. 101
4.6.3 Opportunities and challenges for programmersp. 102
4.7 Planning a Study to Evaluate Accuracyp. 103
4.7.1 Getting help from a statisticianp. 103
4.7.2 Choosing a measurement scalep. 103
4.7.3 Optimizing designp. 104
4.7.4 Carrying out different phases of researchp. 108
4.7.5 An example from another fieldp. 109
4.8 Conclusionp. 110
4.9 Appendix: Measures of Binary Test Performancep. 120
5 Retinal Markers for Early Detection of Eye Diseasep. 121
5.1 Abstractp. 121
5.2 Introductionp. 122
5.3 Nonproliferative Diabetic Retinopathyp. 123
5.4 Chapter Overviewp. 124
5.5 Related Works on Identification of Retinal Exudates and the Optic Discp. 128
5.5.1 Exudate identification and classificationp. 128
5.5.2 Optic disc detectionp. 130
5.6 Preprocessingp. 132
5.7 Pixel-Level Exudate Recognitionp. 134
5.8 Application of Pixel-Level Exudate Recognition on the Whole Retinal Imagep. 137
5.9 Locating the Optic Disc in Retinal Imagesp. 139
5.9.1 Template matchingp. 141
5.9.2 Color morphology preprocessingp. 141
5.9.3 Accurate localization of the optic disc-based snakesp. 144
5.9.4 Optic disc localization resultsp. 146
5.10 Conclusionp. 148
6 Automated Microaneurysm Detection for Screeningp. 155
6.1 Characteristics of Microaneurysms and Dot-Hemorrhagesp. 155
6.2 History of Automated Microaneurysm Detectionp. 156
6.2.1 Early morphological approachesp. 156
6.2.2 The "standard approach" to automated microaneurysm detectionp. 157
6.2.3 Extensions of the standard approachp. 159
6.2.4 Other approachesp. 162
6.2.5 General red lesion detectionp. 164
6.3 Microaneurysm Detection in Color Retinal Imagesp. 165
6.4 The Waikato Automated Microaneurysm Detectorp. 167
6.4.1 Further comments on the use of colorp. 171
6.5 Issues for Microaneurysm Detectionp. 172
6.5.1 Image quality assessmentp. 172
6.5.2 Image compression implicationsp. 173
6.5.3 Optic disc detectionp. 175
6.5.4 Meaningful comparisons of implementationsp. 175
6.6 Research Application of Microaneurysm Detectionp. 177
6.7 Conclusionp. 178
7 Retinal Vascular Changes as Btomarkers of Systemic Cardiovascular Diseasesp. 185
7.1 Introductionp. 185
7.2 Early Description of Retinal Vascular Changesp. 186
7.3 Retinal Vascular Imagingp. 187
7.3.1 Assessment of retinal vascular signs from retinal photographsp. 187
7.3.2 Limitations in current retinal vascular imaging techniquesp. 187
7.4 Retina] Vascular Changes and Cardiovascular Diseasep. 189
7.4.1 Hypertensionp. 189
7.4.2 Stroke and cerebrovascular diseasep. 191
7.4.3 Coronary heart disease and congestive heart failurep. 193
7.5 Retinal Vascular Changes and Metabolic Diseasesp. 194
7.5.1 Diabetes mellitusp. 196
7.5.2 The metabolic syndromep. 196
7.5.3 Overweight and obesityp. 197
7.6 Retinal Vascular Changes and Other Systemic Diseasesp. 197
7.6.1 Renal diseasep. 197
7.6.2 Atherosclerosisp. 198
7.6.3 Inflammation and endothelial dysfunctionp. 198
7.6.4 Subclinical cardiac morphologyp. 200
7.7 Genetic Associations of Retinal Vascular Changesp. 200
7.8 Conclusionp. 201
7.A Appendix: Retinal Vessel Caliber Grading Protocolp. 201
7.A.1 Grading an imagep. 202
7.A.2 Example of the grading processp. 204
7.A.3 Obtaining resultsp. 205
7.A.4 Saving datap. 206
8 Segmentation of Retinal Vasculature Using Wavelets and Supervised Classification: Theory and Implementationp. 221
8.1 Introductionp. 221
8.2 Theoretical Backgroundp. 224
8.2.1 The 1-D CWTp. 224
8.2.2 The 2-D CWTp. 225
8.2.3 The 2-D Gabor waveletp. 228
8.2.4 Supervised classificationp. 229
8.2.5 Bayesian decision theoryp. 231
8.2.6 Bayesian Gaussian mixture model classifierp. 231
8.2.7 K-nearest neighbor classifierp. 233
8.2.8 Linear minimum squared error classifierp. 234
8.3 Segmentation Using the 2-D Gabor Wavelet and Supervised Classificationp. 235
8.3.1 Preprocessingp. 235
8.3.2 2-D Gabor wavelet featuresp. 237
8.3.3 Feature normalizationp. 238
8.3.4 Supervised pixel classificationp. 239
8.3.5 Public image databasesp. 240
8.3.6 Experiments and settingsp. 241
8.3.7 ROC analysisp. 242
8.4 Implementation and Graphical User Interfacep. 245
8.4.1 Overviewp. 245
8.4.2 Installationp. 246
8.4.3 Command line interfacep. 246
8.4.4 Graphical user interfacep. 247
8.5 Experimental Resultsp. 249
8.6 Conclusionp. 258
8.6.1 Summaryp. 258
8.6.2 Future workp. 258
9 Determining Retinal Vessel Widths and Detection of Width Changesp. 269
9.1 Identifying Blood Vesselsp. 270
9.2 Vessel Modelsp. 270
9.3 Vessel Extraction Methodsp. 271
9.4 Can's Vessel Extraction Algorithmp. 271
9.4.1 Improving Can's algorithmp. 272
9.4.2 Limitations of the modified Can algorithmp. 275
9.5 Measuring Vessel Widthp. 276
9.6 Precise Boundary Detectionp. 278
9.7 Continuous Vessel Models with Spline-Based Ribbonsp. 279
9.7.1 Spline representation of vesselsp. 279
9.7.2 B-spline ribbonsp. 284
9.8 Estimation of Vessel Boundaries Using Snakesp. 288
9.8.1 Snakesp. 288
9.8.2 Ribbon snakesp. 289
9.8.3 B-spline ribbon snakep. 289
9.8.4 Cross section-based B-spline snakesp. 292
9.8.5 B-spline ribbon snakes comparisonp. 293
9.9 Vessel Width Change Detectionp. 294
9.9.1 Methodologyp. 294
9.9.2 Change detection via hypothesis testp. 296
9.9.3 Summaryp. 298
9.10 Conclusionp. 298
10 Geometrical and Topological Analysis of Vascular Branches from Fundus Retinal Imagesp. 305
10.1 Introductionp. 305
10.2 Geometry of Vessel Segments and Bifurcationsp. 306
10.2.1 Arterial to venous diameter ratiop. 306
10.2.2 Bifurcation geometryp. 308
10.2.3 Vessel length to diameter ratiosp. 311
10.2.4 Tortuosityp. 312
10.3 Vessel Diameter Measurements from Retinal Imagesp. 312
10.3.1 The half-height methodp. 313
10.3.2 Double Gaussian fittingp. 314
10.3.3 The sliding linear regression filter (SLRF)p. 314
10.4 Clinical Findings from Retinal Vascular Geometryp. 315
10.5 Topology of the Vascular Treep. 318
10.5.1 Strahler branching ratiop. 321
10.5.2 Path lengthp. 321
10.5.3 Number of edgesp. 321
10.5.4 Tree asymmetry indexp. 322
10.6 Automated Segmentation and Analysis of Retinal Fundus Imagesp. 323
10.6.1 Feature extractionp. 324
10.6.2 Region growingp. 326
10.6.3 Analysis of binary imagesp. 327
10.7 Clinical Findings from Retinal Vascular Topologyp. 328
10.8 Conclusionp. 329
11 Tele-Diabetic Retinopathy Screening and Image-Based Clinical Decision Supportp. 339
11.1 Introductionp. 339
11.2 Telemedicinep. 339
11.2.1 Image capturep. 340
11.2.2 Image resolutionp. 341
11.2.3 Image transmissionp. 342
11.2.4 Image compressionp. 342
11.3 Telemedicine Screening for Diabetic Retinopathyp. 344
11.4 Image-Based Clinical Decision Support Systemsp. 346
11.5 Conclusionp. 347
Indexp. 351